In psoriasis patients treated with IL-17 inhibitors, levels of Bacteroides stercoris and Parabacteroides merdae were significantly increased at week 24, while those of Blautia and Roseburia were significantly reduced by 16S rRNA gene sequencing (Huang et al., 2023). Here, IL17A is linked to psoriasis.